Timeline
Mapp Biopharmaceutical
A US-based biopharmaceutical company known for developing plant-derived monoclonal antibodies against filoviruses, including ZMapp for Zaire Ebola and MBP134 for pan-Ebola coverage including Bundibugyo.
2 of 2 entries (2 events, 0 interactions)
Filters
#5 1 Jun
Mentioned in: Only Ebola treatment still cannot dose
Pandemics and Biosecurity#4 20 May